mesalamine has been researched along with metronidazole in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (10.91) | 18.7374 |
| 1990's | 17 (30.91) | 18.2507 |
| 2000's | 18 (32.73) | 29.6817 |
| 2010's | 13 (23.64) | 24.3611 |
| 2020's | 1 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Farhat, M; George, RF; Girgis, AS; Katritzky, AR; Naumov, RN; Panda, SS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Crouch, R; Davis, AE; Patterson, F | 1 |
| Cohen, SA; Daum, F; Glassman, M; Holmes, RD; Markowitz, J; Piccoli, D; Rossi, TM; Treem, WR; Ulshen, MH; Winter, HS | 1 |
| Hartmann, F; Plauth, M | 1 |
| Feurle, GE | 1 |
| Kreisel, W; Rasenack, J | 1 |
| Peppercorn, MA | 1 |
| Sachar, DB | 1 |
| Van Rosendaal, GM | 1 |
| Gerok, W; Schölmerich, J | 1 |
| Sutherland, LR | 1 |
| Daiss, W; Dölle, W | 1 |
| Barker, LA; Winbery, SL | 1 |
| Okada, M; Yao, T | 1 |
| Arcanà, F; Basso, L; Buffatti, P; Di Bella, F; Doldi, A; Forcheri, V; Gaetini, R; Interisano, A; Pera, A; Pescatori, M | 1 |
| van Hogezand, RA | 1 |
| Bonner, GF | 1 |
| McCaulley, ME | 1 |
| Haga, Y; Munakata, A | 1 |
| Rutgeerts, P; Vermeire, S | 1 |
| Sarigol, S; Wyllie, R | 1 |
| Breslin, NP; Sutherland, LR | 1 |
| Buffinton, GD; Doe, WF; McKenzie, SM | 1 |
| Blake, DR; Millar, AD; Rampton, DS; Simmonds, NJ | 1 |
| Hiwatashi, N | 1 |
| Achkar, JP; Hanauer, SB | 1 |
| Cavcić, J; Jelincić, Z; Martinac, P; Panijan-Pezerović, R; Turcić, J; Unusić, J; Zupancić, B | 1 |
| Alkim, C; Dağli, U; Parlak, E; Sahin, B; Ulker, A | 1 |
| Amadini, C; Campieri, M; Gionchetti, P; Rizzello, F; Venturi, A | 1 |
| Färkkilä, M; Järvinen, HJ; Jussila, A | 1 |
| Alarcón, A; Martínez, JG; Morey, A; Saus, C | 1 |
| Beglinger, Ch | 1 |
| Calabrese, E; Cammà, C; Casà, A; Cottone, M; Orlando, A; Viscido, A | 1 |
| Alazmi, WM; Barkin, JS; Erim, T; O'Loughlin, CJ | 1 |
| Aydogan, H; Gulec, B; Kilinc, M; Kozak, O; Ozcan, A; Pekcan, M; Yigit, T; Yigitler, C | 1 |
| Berenguer, J; Del Valle, E; Hernández, C; Jara, J; Martínez-Salamanca, JI; Miralles, P | 1 |
| Avilés-Izquierdo, JA; Lázaro-Ochaita, P; Longo-Imedio, I; Suárez-Fernández, R | 1 |
| Boubaker, J; Filali, A; Kallel, L; Karoui, S | 1 |
| Detsky, A; Kennedy, ED; Llewellyn-Thomas, HA; McLeod, RS; Steinhart, AH; To, T | 1 |
| Bell, AJ; Ciclitira, PJ; Clark, SK; McLaughlin, SD; Nicholls, RJ; Tekkis, PP | 1 |
| Lakatos, L; Lakatos, PL | 1 |
| Hu, PJ; Lin, XC; Tai, WP; Wu, J | 1 |
| Suo, J; Wang, Z | 1 |
| Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A | 1 |
| Hirata, Y; Joh, T; Kamiya, T; Kataoka, H; Mizoshita, T; Mizushima, T; Murakami, K; Ozeki, K; Shimura, T; Tanida, S; Tsukamoto, H | 1 |
| Giles, HW; Nowicki, MJ; Ray, LI; Thomas, KS | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, GM; Giorgio, F; Ierardi, E; Inchingolo, CD; Nenna, R; Picchio, M; Tursi, A | 1 |
| Barrett, K; Corcoran, M; Inglis, S; Martin, P; Pierce, D; Preston, P; Thompson, TN; Willsie, SK | 1 |
| Kim, HW; Ko, JY; Park, CG; Park, HC | 1 |
| Goumas, C; Karatza, E; Muenster, U; Reppas, C; Vertzoni, M | 1 |
| Bravo-Soto, GA; Candia, R; Hernandez, C; Monrroy, H; Nguyen, GC | 1 |
23 review(s) available for mesalamine and metronidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Conservative therapy of Crohn disease--reliable measures based on clinical studies].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1991 |
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1990 |
[Conservative therapy of ulcerative colitis and Crohn disease].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole | 1991 |
Advances in drug therapy for inflammatory bowel disease.
Topics: Administration, Oral; Administration, Topical; Adrenocorticotropic Hormone; Aminosalicylic Acids; Anti-Inflammatory Agents; Enema; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole | 1990 |
Inflammatory bowel disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Delayed-Action Preparations; Drug Evaluation; Forecasting; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Sulfasalazine | 1989 |
Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Food, Formulated; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Parenteral Nutrition, Total; Sulfasalazine | 1987 |
[Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1988 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Current medical therapy for inflammatory bowel disease.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Crohn Disease; Fatty Acids, Volatile; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Nicotine | 1996 |
[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].
Topics: Anti-Inflammatory Agents; Budesonide; Colon; Crohn Disease; Follow-Up Studies; Humans; Ileum; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 1998 |
The treatment of inflammatory bowel disease in children.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Metronidazole; Sulfasalazine | 1998 |
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Digestive System Surgical Procedures; Humans; Mesalamine; Metronidazole; Postoperative Period; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention | 1998 |
[Medical treatment of Crohn's disease].
Topics: Antibodies, Monoclonal; Azathioprine; CD4 Antigens; Crohn Disease; Enteral Nutrition; Heparin; Humans; Immunosuppressive Agents; Interleukin-10; Mesalamine; Metronidazole; Prednisolone; Tumor Necrosis Factor-alpha | 2000 |
Medical therapy to reduce postoperative Crohn's disease recurrence.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Recurrence; Risk Factors; Sulfasalazine | 2000 |
Review article: treatment of mild to moderate ulcerative colitis and pouchitis.
Topics: Administration, Oral; Administration, Rectal; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Glucocorticoids; Humans; Mesalamine; Metronidazole; Pouchitis | 2002 |
[Can the postoperative relapse of Crohn disease be influenced?].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 2001 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Ornidazole; Probiotics; Risk Factors; Secondary Prevention; Smoking | 2003 |
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Topics: Algorithms; Anastomosis, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy; Female; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Metronidazole; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Risk Factors; Secondary Prevention; Smoking; Time Factors | 2006 |
[Postoperative recurrence of Crohn's disease, and its prevention].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Period; Recurrence; Risk Factors | 2010 |
Sternoclavicular joint arthritis as the initial presentation of Crohn's disease in an adolescent.
Topics: Adolescent; Arthralgia; Arthritis; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Mesalamine; Metronidazole; Prednisone; Ranitidine; Severity of Illness Index; Sternoclavicular Joint; Treatment Outcome | 2013 |
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Topics: Adalimumab; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Bias; Cohort Studies; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Purines; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha | 2020 |
6 trial(s) available for mesalamine and metronidazole
| Article | Year |
|---|---|
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Sulfasalazine | 1990 |
[Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporins; Humans; Mesalamine; Metronidazole; Sulfasalazine | 1986 |
Management of perianal Crohn's disease. Results of a multicenter study in Italy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anus Diseases; Child; Colostomy; Crohn Disease; Female; Follow-Up Studies; Humans; Ileostomy; Male; Mesalamine; Metronidazole; Middle Aged; Reoperation; Sulfasalazine; Treatment Outcome | 1995 |
Metronidazole in the treatment of chronic radiation proctitis: clinical trial.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Chronic Disease; Drug Therapy, Combination; Enema; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Proctitis; Prostatic Neoplasms; Radiation Injuries; Treatment Outcome | 2000 |
Comparison of 5-amino salicylic acid plus glucocorticosteroid with metronidazole and ciprofloxacin in patients with active ulcerative colitis.
Topics: Adult; Ciprofloxacin; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Long-Term Care; Male; Mesalamine; Metronidazole; Middle Aged; Treatment Outcome | 2001 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Sulfamethoxazole | 2014 |
27 other study(ies) available for mesalamine and metronidazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates.
Topics: Animals; Anti-Inflammatory Agents; Indomethacin; Mesalamine; Metronidazole; Mice; Molecular Structure; Quantitative Structure-Activity Relationship; Stomach Ulcer | 2015 |
The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.
Topics: Adenocarcinoma; Aminosalicylic Acids; Animals; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Incidence; Inflammatory Bowel Diseases; Male; Mesalamine; Metronidazole; Neoplasm Invasiveness; Rats; Rats, Wistar; Sulfasalazine | 1992 |
Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lipoxygenase Inhibitors; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole; Steroids | 1991 |
1989 Henry Baker lecture. Inflammatory bowel disease: back to the future.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Awards and Prizes; Colorectal Neoplasms; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Metronidazole; Risk Factors; Societies, Medical; United States | 1990 |
Metronidazole and 5-aminosalicylic acid enhance the contractile activity of histaminergic agonists on the guinea-pig isolated ileum.
Topics: Aminosalicylic Acids; Animals; Cimetidine; Computers; Dimaprit; Dose-Response Relationship, Drug; Drug Synergism; Duodenum; Female; Guinea Pigs; Heart; Histamine; Ileum; In Vitro Techniques; Jejunum; Male; Mesalamine; Metronidazole; Muscle Contraction; Myenteric Plexus; Pyrilamine; Receptors, Histamine; Scopolamine; Tetrodotoxin; Thiourea | 1986 |
[Inflammatory bowel disease; internal therapy].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Humans; Hydrocortisone; Immunosuppressive Agents; Mesalamine; Metronidazole; Parenteral Nutrition, Total; Prednisolone; Sulfapyridine | 1988 |
Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Mesalamine; Metronidazole; Prednisone; Purpura, Thrombocytopenic, Idiopathic | 1996 |
[Current medical therapies for Crohn's disease in Japan].
Topics: Aminosalicylic Acids; Crohn Disease; Food, Fortified; Gastrointestinal Agents; Humans; Japan; Mesalamine; Metronidazole; Prednisone; Sulfasalazine | 1997 |
5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Colon; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hypochlorous Acid; Mercaptopurine; Mesalamine; Methylprednisolone; Metronidazole; Oxidants; Oxidative Stress | 1999 |
Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Cell-Free System; Colitis; Female; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Luminescent Measurements; Male; Mesalamine; Metronidazole; Middle Aged; Phenylhydrazines; Proctitis; Steroids | 1999 |
[Crohn's disease and renal amyloidosis. Acute renal failure].
Topics: Acetaminophen; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Amyloidosis; Analgesics, Non-Narcotic; Aspirin; Autoimmune Diseases; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mesalamine; Metronidazole; Renal Dialysis; Substance-Related Disorders | 2002 |
Collagenous colitis associated with Clostridium difficile: a cause effect?
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clostridioides difficile; Colitis; Enterocolitis, Pseudomembranous; Humans; Male; Mesalamine; Metronidazole; Treatment Outcome | 2003 |
Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Colitis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Mesalamine; Metronidazole; Models, Animal; Rats; Rats, Sprague-Dawley | 2004 |
Metastatic crohn's disease--penile and scrotal involvement.
Topics: Adult; Biopsy, Needle; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Male; Mesalamine; Metronidazole; Penile Diseases; Prednisone; Risk Assessment; Scrotum; Severity of Illness Index; Skin Ulcer; Treatment Outcome | 2004 |
Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Crohn Disease; Diagnosis, Differential; Granuloma; HIV Infections; Humans; Male; Mesalamine; Metronidazole; Penile Diseases; Prednisone; Pyoderma Gangrenosum | 2005 |
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
Topics: Adult; Aged; Azathioprine; Budesonide; Canada; Crohn Disease; Cross-Sectional Studies; Decision Support Techniques; Fees, Pharmaceutical; Female; Fish Oils; Focus Groups; Gastrointestinal Agents; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Patient Satisfaction; Postoperative Care; Regression Analysis; Reproducibility of Results; Secondary Prevention | 2008 |
Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Female; Humans; Ileitis; Incidence; Male; Mesalamine; Metronidazole; Middle Aged; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Retrospective Studies | 2009 |
Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Blastocystis hominis; Blastocystis Infections; China; Colitis, Ulcerative; Comorbidity; Feces; Female; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Sulfasalazine; Treatment Outcome | 2011 |
Preparation of a composite fibrous membrane loaded with mesalazine and metronidazole by interlaced electrospinning.
Topics: Drug Carriers; Drug Stability; Lactic Acid; Membranes, Artificial; Mesalamine; Metronidazole; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared | 2012 |
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anus Diseases; Azathioprine; Ciprofloxacin; Crohn Disease; Cutaneous Fistula; Endosonography; Female; Humans; Immunosuppressive Agents; Incidental Findings; Infliximab; Male; Mercaptopurine; Mesalamine; Metronidazole; Middle Aged; Rectal Fistula; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Colonoscopy; Combined Modality Therapy; Crohn Disease; Granulocytes; Humans; Immunosuppressive Agents; Leukapheresis; Leukocyte Reduction Procedures; Male; Mercaptopurine; Mesalamine; Metronidazole; Monocytes; Parenteral Nutrition, Total; Prednisolone; Remission Induction; Young Adult | 2012 |
Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis; Colitis, Ulcerative; Colon; Diverticulitis, Colonic; Diverticulosis, Colonic; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Humans; Inflammation; Intestinal Mucosa; Male; Mesalamine; Metronidazole; Middle Aged; Rifamycins; Rifaximin; Syndecan-1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Metastatic Crohn disease clinically reminiscent of erythema nodosum on the right leg.
Topics: Adult; Anti-Inflammatory Agents; Colonoscopy; Crohn Disease; Erythema Nodosum; Female; Glucocorticoids; Granuloma; Humans; Leg; Mesalamine; Metronidazole; Skin; Treatment Outcome | 2016 |
Ex vivo evaluation of degradation rates of metronidazole and olsalazine in distal ileum and in cecum: The impact of prandial state.
Topics: Adult; Aminosalicylic Acids; Bacteria; Cecum; Fasting; Humans; Ileum; Mesalamine; Metronidazole | 2017 |